Related Experiment Video

Updated: Oct 26, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes

Y Kitamura1, H Sasamura, T Maruyama

  • 1Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

Molecular and Cellular Endocrinology
|December 24, 1998
PubMed

Insights

Researchers investigated gene expression in adrenal tumors causing Cushing's and Conn's syndromes. AT2 receptor mRNA levels were significantly decreased in these tumors, suggesting a correlation between AT2 receptor and adrenal tumorigenesis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Cushing's and Conn's syndromes are endocrine disorders caused by adrenal tumors.
  • The specific molecular mechanisms driving adrenal tumor development remain unclear.

Purpose of the Study:

  • To investigate the gene expression of angiotensin II receptors (AT1 and AT2) in adrenal adenomas associated with Cushing's and Conn's syndromes.
  • To determine the role of AT1 and AT2 receptor subtypes in the pathobiology of these adrenal tumors.

Main Methods:

  • Gene expression analysis using Reverse Transcription Polymerase Chain Reaction (RT-PCR).
  • Quantification of AT1 and AT2 receptor mRNA levels in adrenal adenomas.
  • Comparison of gene expression in tumor tissue versus adjacent normal adrenal cortex.

Main Results:

  • AT2 receptor mRNA levels were significantly decreased in adrenal adenomas of both Cushing's and Conn's syndromes compared to normal adrenal cortex.
  • No consistent differences in AT1 receptor mRNA levels were observed between tumors and normal tissue.
  • Alternative splicing of AT1 mRNA showed no significant changes in the adrenal tumors.

Conclusions:

  • The findings suggest that reduced AT2 receptor expression, not AT1 receptor expression or splicing, may be linked to the development of adrenal tumors causing Cushing's and Conn's syndromes.
  • The AT2 receptor warrants further investigation as a potential factor in adrenal tumorigenesis.

More Related Videos

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex07:43

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex

Published on: May 8, 2026

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...